Nafagrel (hydrochloride)

Nafagrel hydrochloride is a thromboxane A2 synthetase inhibitor. Nafagrel hydrochloride can prevent the accumulation of thrombus material in a rat model of acute arterial thrombosis[1][2].

Product Specifications

CAS Number

[97901-22-9]

UNSPSC

12352005

Target

Prostaglandin Receptor

Related Pathways

GPCR/G Protein

Field of Research

Cardiovascular Disease

Smiles

OC(C1=CC=C(CC(CN2C=CN=C2)CC3)C3=C1)=O.Cl

Molecular Formula

C15H17ClN2O2

Molecular Weight

292.76

References & Citations

[1]Geiger J. Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin Investig Drugs. 2001 May;10 (5) :865-90. |[2]Bernat A, et al. Effect of various antiplatelet agents on acute arterial thrombosis in the rat. Thromb Haemost. 1993 Nov 15;70 (5) :812-6.